Health In Tech (HIT) Competitors $0.68 +0.02 (+3.37%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock HIT vs. RDZN, ICCH, NEUE, AAME, ZBAO, HUIZ, FGF, OXBR, AIFU, and CNFRShould you be buying Health In Tech stock or one of its competitors? The main competitors of Health In Tech include Roadzen (RDZN), ICC (ICCH), NeueHealth (NEUE), Atlantic American (AAME), Zhibao Technology (ZBAO), Huize (HUIZ), Fundamental Global (FGF), Oxbridge Re (OXBR), AIX (AIFU), and Conifer (CNFR). These companies are all part of the "insurance" industry. Health In Tech vs. Roadzen ICC NeueHealth Atlantic American Zhibao Technology Huize Fundamental Global Oxbridge Re AIX Conifer Roadzen (NASDAQ:RDZN) and Health In Tech (NASDAQ:HIT) are both small-cap finance companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, community ranking, profitability, institutional ownership, valuation, risk, dividends and media sentiment. Do analysts rate RDZN or HIT? Roadzen presently has a consensus target price of $5.00, suggesting a potential upside of 474.65%. Given Roadzen's stronger consensus rating and higher possible upside, equities analysts plainly believe Roadzen is more favorable than Health In Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Roadzen 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Health In Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Which has better earnings and valuation, RDZN or HIT? Health In Tech has lower revenue, but higher earnings than Roadzen. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRoadzen$42.89M1.51-$99.67M-$1.51-0.58Health In Tech$22.38M1.65N/AN/AN/A Do insiders & institutionals have more ownership in RDZN or HIT? 24.7% of Roadzen shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media favor RDZN or HIT? In the previous week, Health In Tech had 5 more articles in the media than Roadzen. MarketBeat recorded 5 mentions for Health In Tech and 0 mentions for Roadzen. Roadzen's average media sentiment score of 0.00 beat Health In Tech's score of -0.30 indicating that Roadzen is being referred to more favorably in the media. Company Overall Sentiment Roadzen Neutral Health In Tech Neutral Is RDZN or HIT more profitable? Health In Tech has a net margin of 0.00% compared to Roadzen's net margin of -248.79%. Company Net Margins Return on Equity Return on Assets Roadzen-248.79% N/A -269.99% Health In Tech N/A N/A N/A Does the MarketBeat Community believe in RDZN or HIT? Roadzen received 3 more outperform votes than Health In Tech when rated by MarketBeat users. CompanyUnderperformOutperformRoadzenOutperform Votes3100.00% Underperform VotesNo VotesHealth In TechN/AN/A SummaryRoadzen beats Health In Tech on 7 of the 11 factors compared between the two stocks. Get Health In Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for HIT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIT vs. The Competition Export to ExcelMetricHealth In TechInsurance Agents, Brokers & Service IndustryFinance SectorNASDAQ ExchangeMarket Cap$37.01M$37.01M$11.49B$8.38BDividend YieldN/AN/A5.46%4.10%P/E RatioN/AN/A22.4819.71Price / Sales1.651.6527.28116.98Price / CashN/AN/A17.6234.62Price / BookN/AN/A2.794.50Net IncomeN/AN/A$1.04B$248.18M7 Day Performance-5.34%-2.67%0.34%1.14%1 Month Performance-0.49%-0.24%8.69%15.18%1 Year PerformanceN/AN/A537.74%6.55% Health In Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HITHealth In TechN/A$0.68+3.4%N/AN/A$37.01M$22.38M0.0079News CoverageGap DownRDZNRoadzen1.3075 of 5 stars$1.13+18.8%$5.00+342.5%-67.1%$83.95M$42.89M-0.75324ICCHICCN/A$23.49flatN/AN/A$73.74M$93.57M10.5890NEUENeueHealth1.2436 of 5 stars$6.90-0.8%$7.00+1.5%+14.2%$61.51M$907.35M-0.131,252AAMEAtlantic American0.7077 of 5 stars$1.72-3.4%N/A+4.3%$35.09M$188.23M-4.91140Analyst ForecastZBAOZhibao TechnologyN/A$1.07+2.9%N/A-69.3%$33.73M$245.79M0.00148Gap UpHUIZHuizeN/A$2.23+1.8%N/A-90.1%$22.50M$1.25B24.781,640Gap UpHigh Trading VolumeFGFFundamental Global1.8062 of 5 stars$16.50-2.8%N/A-38.2%$20.99M$17.35M12.609Earnings ReportOXBROxbridge Re2.1062 of 5 stars$1.93-3.5%$5.00+159.1%-8.4%$14.37M$546,000.00-2.303AIFUAIXN/A$0.18+0.6%N/AN/A$10.14M$1.81B0.245,780Gap DownTrading HaltedCNFRConifer1.5146 of 5 stars$0.82+0.1%N/A-16.1%$10.05M$66.30M0.34150Earnings ReportGap Up Related Companies and Tools Related Companies Roadzen Competitors ICC Competitors NeueHealth Competitors Atlantic American Competitors Zhibao Technology Competitors Huize Competitors Fundamental Global Competitors Oxbridge Re Competitors AIX Competitors Conifer Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:HIT) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredIs President Trump Lying To You With This?President Trump’s economic transition isn’t without hardship. But what if there were a smart, tax-free way to ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health In Tech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health In Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
